default author photo

Francesca Necchi

GSK Vaccines Institute for Global Health

Avenue Fleming 20

Waver, 1300

Belgium

SCHOLARLY PAPERS

3

DOWNLOADS

122

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Efficacy, Safety, and Immunogenicity of the Shigella sonnei 1790GAHB GMMA Candidate Vaccine: Results from a Phase 2b Randomized, Placebo-Controlled Challenge Study in Adults

Number of pages: 33 Posted: 02 Mar 2021
Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, GSK Vaccines Institute for Global Health, GSK, GSK, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, Fondazione Toscana Life Sciences - Monoclonal Antibody Discovery Lab (MAD), Burnet Institute, GSK Vaccines Institute for Global Health and GSK Vaccines Institute for Global Health
Downloads 122 (588,531)

Abstract:

Loading...

Shigella sonnei, 1790GAHB vaccine, GMMA, human challenge study, controlled human infection model, shigellosis

2.

Strep a Vaccine: From Formulation Development to Toxicology Lot Production

16TH VACCINE CONGRESS:P2.58
Posted: 19 Oct 2022
affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, GlaxoSmithKline - Vaccines, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, GlaxoSmithKline - Vaccines, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN

Abstract:

Loading...

3.

Manufacturing and Analytical Development of a Sustainable Vaccine Against Invasive Nontyphoidal Salmonellosis and Typhoid Fever

16TH VACCINE CONGRESS:P2.54
Posted: 19 Oct 2022
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, affiliation not provided to SSRN and affiliation not provided to SSRN

Abstract:

Loading...